Electricity co-operation post-Brexit has far more positives than negatives Date Monday, January 06, 2025 - 8:38 AM Description A simple trading agreement would suit both Europe and the UK
Electricity infrastructure is the next play for AI investors Date Monday, September 16, 2024 - 12:30 PM Description Power and battery providers offer another way to ride the AI wave
Elektra at London’s Royal Opera House review — Antonio Pappano bows out in high style Image Date Monday, January 15, 2024 - 7:32 AM Description The conductor conjures high-quality playing from the orchestra, though the singing doesn’t quite reach the same standards
Elephant invasion pits Zambian villagers against conservationists Date Monday, June 03, 2024 - 10:00 PM Description Devastation caused by animals highlights tension between global environmentalists and locals that live alongside wildlife
Eleven countries to breach EU deficit rules Date Sunday, April 28, 2024 - 10:00 PM Description Poland and others push to be exempt from ‘excessive deficit procedure’ owing to their high defence spending
Eleven EU countries push for conclusion of Mercosur trade deal Date Thursday, September 05, 2024 - 11:00 PM Description Also in this newsletter: Brussels changes tack on Italy’s beach bonanza.
Elgar: The Dream of Gerontius — Paul McCreesh combines Anglican chant with Wagnerian opera Date Wednesday, April 17, 2024 - 10:00 AM Description The conductor leads the Gabrieli Consort and Players in this wide-ranging score
Elhedery grasps the HSBC nettle Date Friday, January 31, 2025 - 11:00 AM Description The bank’s retreat in parts of investment banking marks a change after a long journey in the business
Eli Lilly in advanced talks to buy US cancer biotech for up to $2.5bn Date Friday, January 10, 2025 - 11:26 AM Description Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers
Eli Lilly launches cheaper vial version of blockbuster weight-loss drug Date Tuesday, August 27, 2024 - 9:01 AM Description US group races to overcome production bottleneck to meet demand for anti-obesity medicine Zepbound